Showing 61-70 of 3101 results for "".
MS Minute: Late-Breaking Data From ECTRIMS—Evobrutinib Safety and Efficacy
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-late-breaking-data-from-ectrimsevobrutinib-safety-and-efficacy/30164/A potential new first-in-class treatment affects Bruton's tyrosine kinase.Multiple Sclerosis Minute: Physical Activity & MS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-minute-physical-activity-ms/31830/Exercise training has benefits for multiple sclerosis, is safe, and should be prescribed.Does Epstein-Barr Virus Cause MS?
https://practicalneurology.com/programs/practical-neurology/does-epstein-barr-virus-cause-ms/30104/Is EBV the Cause of Multiple Sclerosis? Viruses have long been implicated in the pathogenesis of multiple sclerosis, but no single virus has been found to be the cause. Could Epstein-Barr Virus—or EBV—be the culprit? Listen to the experts debate!A Once-Daily Oral Therapy for Relapsing MS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/a-once-daily-oral-therapy-for-relapsing-ms/31907/Data from a phase 3, head-to-head study support the efficacy and safety profile of this DMT.Treating Pain in the Context of the Opioid Crisis
https://practicalneurology.com/diseases-diagnoses/headache-pain/treating-pain-in-the-context-of-the-opioid-crisis/30266/An interview with pain specialist Paul Christo, MD, MBA.MS Minute: Update on BTK Inhibitors for Multiple Sclerosis—A New Treatment That Brings New Hope
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/update-on-btk-inhibitors-for-multiple-sclerosis-a-new-treatment-that-brings-new-hope/40007/BTK inhibitors are the first class of medications to slow disability progression in secondary progressive multiple sclerosis without clinical relapses.Learning, Laughing, and Living with Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/learning-laughing-and-living-with-multiple-sclerosis/37228/Ardra Shephard, a musician, author, fashion-show TV host, podcaster, and MS advocate, discusses her experiences living with MS, including how she uses her story to educate and encourage others living with MS. She is joined by Jiwon Oh, MD, Medical Director of the Barlo Multiple Sclerosis Program atSeeking Breakthroughs: The Industry Perspective
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-industry-perspective/30192/A roundtable discussion with Gregory Went, PhD, Adamas Pharmaceuticals; Lynn Kramer, MD, Eisai; Paulo Fontoura, MD, PhD, Genentech/Roche; Justin Gover, BSc, MBA, GW Pharmaceuticals; Marc Kamin, MD, SK Life Sciences; and Mike Davis, BSc, MBA, UCBOptic Neuritis: Update on Diagnosis, Management, and Long-term Follow-up
https://practicalneurology.com/columns/practice-management/PN1009_02-php/30879/Specialists share insights on diagnostic tools, prospects for neuroprotective therapies, and the risk of MS.Detecting Multiple Sclerosis Earlier: PRLs and the Evolving McDonald Diagnostic Criteria
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/detecting-multiple-sclerosis-earlier-prls-and-the-evolving-mcdonald-diagnostic-criteria/54390/This episode explores new evidence showing that paramagnetic rim lesions (PRLs) are highly prevalent early in multiple sclerosis (MS) and can differentiate MS from mimics with striking accuracy. Daniel Ontaneda, MD, PhD, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, and Pascal Sati, Ph